Problems with API solid state are often overlooked in drug development. Selecting a sub-optimal version, lack of polymorph control, and poor design of the API step can halt a clinical program or delay commercialisation.
My SME expertise covers: Risk based development, version screening, polymorphism, hydration and solvation, API crystallisation development, downstream processing, filtration, washing and drying, particle size reduction, crystallization scale-up, quality by design, technical transfer, physical properties data interpretation.
Company Details
- Founded
- 2020
- Address
- London, Gb
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://apiparticle.com
- Keywords
- covers: Risk based development.
- HQ
- London
- Competitors
- ANTHRO API-GEN (PVT.) LTD Pharmaceuticals, TEVA API INTERNATIONAL SA, CertQuim - API standards, Ingredients, Chemicals, Vivan Meditech Pharma API, Coalition of API Producers (CAPIP), Tehran Chemie API Company, API Tablet Press, Relax Lactulose API and Finished Product, API 5.0 d.o.o., API-NORM NATURAL.
Api Particle Development Questions
Api Particle Development's website is https://apiparticle.com
Api Particle Development's LinkedIn profile is https://uk.linkedin.com/company/api-particle-development
Api Particle Development's industry is
Pharmaceutical Manufacturing
Api Particle Development's top competitors are
Anthro Api-Gen (Pvt.) Ltd Pharmaceuticals,
Teva Api International Sa,
Certquim - Api Standards, Ingredients, Chemicals,
Vivan Meditech Pharma Api,
Coalition Of Api Producers (Capip),
Tehran Chemie Api Company,
Api Tablet Press,
Relax Lactulose Api And Finished Product,
Api 5.0 D.o.o.,
Api-Norm Natural.
Api Particle Development's categories are Pharmaceutical Manufacturing
Api Particle Development's founding year is 2020
